Published in Aliment Pharmacol Ther on June 01, 1998
Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.13
Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.09
Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway. Br J Pharmacol (2002) 0.93
Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.89
Beta-3 adrenergic stimulation of L-type Ca(2+) channels in rat portal vein myocytes. Br J Pharmacol (2000) 0.88
Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: involvement of beta1- and beta2-adrenergic receptors. Am J Physiol Gastrointest Liver Physiol (2009) 0.83
Small bowel review: normal physiology part 2. Dig Dis Sci (2001) 0.81
Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population. J Cancer Res Clin Oncol (2014) 0.79
Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle. Gut (2000) 0.78
Multi-analytic approach elucidates significant role of hormonal and hepatocanalicular transporter genetic variants in gallstone disease in North Indian population. PLoS One (2013) 0.78
Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism. J Comput Aided Mol Des (2005) 0.77
A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations. Int J Mol Sci (2015) 0.75
Enteric neurons of the esophagus: an immunohistochemical study using donated elderly cadavers. Surg Radiol Anat (2017) 0.75
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
A simple clinical colitis activity index. Gut (1998) 4.35
Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13
Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut (1976) 3.75
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
Granulomatous vasculitis in Crohn's disease. Gastroenterology (1991) 2.72
A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet (1998) 2.68
24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet (1975) 2.67
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
MMR vaccination and autism. Lancet (1999) 2.55
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev (2000) 2.47
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology (1999) 2.39
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 2.30
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest (1993) 2.16
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol (2002) 2.07
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology (1992) 2.00
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Crohn's disease after in-utero measles virus exposure. Lancet (1996) 1.98
Model of medical treatment for duodenal ulcer. Lancet (1981) 1.98
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol (1993) 1.94
Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology (1999) 1.90
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut (1977) 1.87
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut (1976) 1.82
DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology (1992) 1.80
Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci U S A (1980) 1.80
A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther (1996) 1.79
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet (2001) 1.79
A rabbit with the allotypic phenotype: ala2a3 b4b5b6. J Immunol (1974) 1.77
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci (1994) 1.76
QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol (1990) 1.76
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol (2001) 1.75
Internalization of beta-adrenergic receptor in A431 cells involves non-coated vesicles. Eur J Cell Biol (1989) 1.71
Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology (1995) 1.69
Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol (1998) 1.69
Serum -glytamyl transpeptidase activity in liver disease. Gut (1972) 1.69
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry (2002) 1.67
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol (1988) 1.67
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.65
Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J (1991) 1.65
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci U S A (1987) 1.62
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet (1995) 1.58
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol (1998) 1.56
Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol (1994) 1.55
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.52
Healing of gastric ulcer during treatment with cimetidine. Lancet (1976) 1.52
The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther (1991) 1.51
Helicobacter pylori and gastroduodenal secretory function. Gastroenterology (1996) 1.50
Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology (1996) 1.49
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem (1994) 1.46
Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol (1995) 1.46
The initial care of newborn infants and subsequent hay fever. Allergy (2000) 1.46
Duodenal ulcers that will not heal. Gut (1984) 1.45
Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol (1998) 1.44
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci (Lond) (1991) 1.42
Pertussis infection in childhood and subsequent type 1 diabetes mellitus. Diabet Med (2002) 1.40
Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing? Arch Pathol Lab Med (2005) 1.39
Management issues for debate: the problems in perspective. Aliment Pharmacol Ther (1993) 1.39
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology (2001) 1.34